Executive Director, Research – Integrative Sciences — Hematology-Oncology

Job description

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it. About Integrative SciencesIntegrative Sciences is the external innovation engine of BMS Research. The group identifies and shapes collaborations with biotech, academic, platform, and venture partners that complement internal Discovery and Early Development priorities. Integrative Sciences connects Research strategy with external opportunity flow, working closely with Business Development, Global Alliance Management, Thematic Research Centers, and Therapeutic Area leadership to convert promising science into decision-ready, industry-workable collaborations. The group is expected to source strategically, triage rigorously, shape executable collaboration plans, manage scientific relationships effectively, and ensure external innovation strengthens the BMS pipeline and the broader Research operating system. Position SummaryThe Executive Director is a senior leader within Integrative Sciences focused on hematology-oncology external innovation, and serves as a key interface across Global Research, Early Development, Business Development, Alliance Management, and external collaboration partners. The role is responsible for identifying, evaluating, and advancing high-value external scientific opportunities, collaborations, and assets in hematologic malignancies and solid tumors. Where appropriate the Executive Director will participate in Site Leadership teams. Where appropriate, the Executive Director may serve as a Board Observer, or in other relevant governance roles, for external hematology-oncology companies on behalf of BMS. This position sits within the BMS Research organization and reports to the U.S. Head of Integrative Sciences. Travel is approximately 30%, domestic and international. The preferred location is Cambridge, MA (CMX); remote arrangements will be considered on a case-by-case basis. Key ResponsibilitiesStrategy and Opportunity TriageCommunicate internal Hematology-Oncology Research pipeline priorities to the Integrative Sciences group, and align external search, evaluation, and triage activities with BMS Research principles and the Enterprise Hematology-Oncology Therapeutic Area strategy. Lead the Hematology-Oncology triage process within Integrative Sciences, ensuring disciplined, criteria-driven evaluation of external opportunities. Identify, evaluate, and bring forward hematology-oncology opportunities — academic collaborations, biotech partnerships, platform technologies, and pre-IND or IND-stage assets — that add to or complement the internal pipeline. Form and lead cross-functional diligence teams for the evaluation of Integrative Sciences collaboration opportunities, and provide expert scientific opinion during Business Development reviews and due diligence. Partner with Search & Evaluation and Business Development transaction leads to advance prioritized opportunities on disciplined, accelerated timelines. Work with Research Finance to ensure activities are aligned, captured, and approved within Research budgets. Collaboration Design and ExecutionContribute to the design and execution of a blended external innovation strategy spanning corporate and academic collaborations. Shape opportunities into practical collaboration plans with clear scientific objectives, work plans, milestones, governance structures, decision points, and success measures. Advise on collaboration structures and contract development as the scientific lead, working closely with Business Development, transaction leads, Legal, and IP. Governance, Representation, and CommunicationServe on joint governance committees and oversight bodies established to coordinate agreed research plans with academic and industry partners, ensuring collaborations remain scientifically focused and operationally accountable. Represent Integrative Sciences, as appropriate, to other BMS organizations, regulatory agencies, investors, partners, and the broader scientific community. Communicate regularly to internal client and partner groups — and their leadership — on external research activities and progress. Compose progress reports and decision documentation for senior management, and deliver presentations and briefings on the scientific and organizational activities within the area of responsibility. LeadershipModel scientific leadership, collaborative behavior, and an enterprise mindset across Research and Integrative Sciences, consistent with BMS values. QualificationsRequiredPhD or equivalent advanced scientific training in cancer biology, hematology, immuno-oncology, or a related discipline relevant to malignant diseases. 10+ years of drug discovery and/or early development experience in the pharmaceutical or biotechnology industry, with deep, hands-on expertise in oncology and/or hematology. Strong understanding of hematologic malignancy and solid tumor biology, with the ability to assess external opportunities against BMS Research priorities. Demonstrated ability to evaluate external scientific opportunities, including academic collaborations, biotech partnerships, platform technologies, and pre-IND or IND-stage assets. Experience shaping external collaboration plans — scientific objectives, work plans, milestones, governance structures, decision points, and success measures — and negotiating them with external partners. Excellent leadership, communication, and problem-solving skills, with the ability to represent Hematology-Oncology external innovation and the broader Integrative Sciences mission to internal and external stakeholders. PreferredTrack record of advancing therapeutic programs toward IND stage or beyond, with knowledge of the scientific, translational, and operational requirements for decision-ready programs. Experience working across Research, Early Development, Business Development, Alliance Management, Legal, IP, Finance, Thematic Research Centers, and Therapeutic Area leadership — or equivalent cross-functional structures — to support disciplined opportunity triage and execution. Strong capability in building productive relationships, setting clear expectations, and keeping collaboration structures scientifically focused and operationally accountable. Understanding of the financial, legal, contractual, and geographic considerations that affect external research collaborations, including non-U.S. partnerships. We hire for skills and capabilities, not just credentials – if this role excites you, but doesn’t perfectly match your resume, we encourage you to apply anyway. Compensation Overview: $263,500 - $319,300 The starting pay range(s) listed above is for full-time employees (FTE). You may also be eligible for additional discretionary incentive cash and stock opportunities. We determine starting pay thoughtfully – carefully considering the nature of the role, required skills, work location, schedule and the knowledge and experience you bring. Final compensation is guided by pay equity principles and applicable employment laws. Compensation programs are reviewed on an ongoing basis and may be adjusted over time to reflect evolving market factors, and individual, team or Company performance. Benefits: Subject to the terms and conditions of the applicable plans then in effect, you may be eligible to participate in our comprehensive benefit plans – including wellbeing support, retirement and financial protection benefits, and insurance offerings (medical, dental, vision, life and disability). U.S.-based exempt